These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 2951263)
1. Identification of interleukin 2-producing T helper cells within murine Lyt-2+ T lymphocytes: frequency, specificity and clonal segregation from Lyt-2+ precursors of cytotoxic T lymphocytes. Heeg K; Steeg C; Hardt C; Wagner H Eur J Immunol; 1987 Feb; 17(2):229-36. PubMed ID: 2951263 [TBL] [Abstract][Full Text] [Related]
2. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants. Golding H; Mizuochi T; McCarthy SA; Cleveland CA; Singer A J Immunol; 1987 Jan; 138(1):10-7. PubMed ID: 2946773 [TBL] [Abstract][Full Text] [Related]
3. Reactivity of Ly-2+ T cells against 2,4,6-trinitrophenyl (TNP)-modified syngeneic stimulator cells: specificity, frequency of interleukin 2-producing Ly-2+ helper T cells and clonal segregation from Ly-2+ cytotoxic T lymphocytes. Schmitt J; Wagner H; Heeg K Eur J Immunol; 1988 Mar; 18(3):325-32. PubMed ID: 2965642 [TBL] [Abstract][Full Text] [Related]
4. Frequency analysis of class I MHC-reactive Lyt-2+ and class II MHC-reactive L3T4+ IL 2-secreting T lymphocytes. Heeg K; Steeg C; Schmitt J; Wagner H J Immunol; 1987 Jun; 138(12):4121-7. PubMed ID: 3108383 [TBL] [Abstract][Full Text] [Related]
5. Quantitative representation of all T cells committed to develop into cytotoxic effector cells and/or interleukin 2 activity-producing helper cells within murine T lymphocyte subsets. Pfizenmaier K; Scheurich P; Däubener W; Krönke M; Röllinghoff M; Wagner H Eur J Immunol; 1984 Jan; 14(1):33-9. PubMed ID: 6229409 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of helper function with anti-Lyt-2 or anti-L3T4 monoclonal antibodies depending on stimulating antigens. Guimezanes A; Schmitt-Verhulst AM Eur J Immunol; 1985 Dec; 15(12):1187-91. PubMed ID: 2935405 [TBL] [Abstract][Full Text] [Related]
7. Differential helper and effector responses of Lyt-2+ T cells to H-2Kb mutant (Kbm) determinants and the appearance of thymic influence on anti-Kbm CTL responsiveness. Mizuochi T; Munitz TI; McCarthy SA; Andrysiak PM; Kung J; Gress RE; Singer A J Immunol; 1986 Nov; 137(9):2740-7. PubMed ID: 2944960 [TBL] [Abstract][Full Text] [Related]
9. Search for class II major histocompatibility complex molecular involvement in the response of Lyt-2+ cytotoxic T lymphocyte precursors to alloantigen. Romani L; Mage MG Eur J Immunol; 1985 Nov; 15(11):1125-30. PubMed ID: 2933265 [TBL] [Abstract][Full Text] [Related]
10. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. Via CS; Sharrow SO; Shearer GM J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440 [TBL] [Abstract][Full Text] [Related]
11. Signal requirements for the in vitro differentiation of cytotoxic T lymphocytes (CTL): distinct soluble mediators promote preactivation of CTL-precursors, clonal growth and differentiation into cytotoxic effector cells. Hardt C; Diamantstein T; Wagner H Eur J Immunol; 1985 May; 15(5):472-8. PubMed ID: 3158532 [TBL] [Abstract][Full Text] [Related]
12. Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells. Kern DE; Klarnet JP; Cheever MA; Greenberg PD Cancer Res; 1990 Oct; 50(19):6256-63. PubMed ID: 2144789 [TBL] [Abstract][Full Text] [Related]
13. Antibodies to the L3T4 and Lyt-2 molecules interfere with antigen receptor-driven activation of cloned murine T cells. Moldwin RL; Havran WL; Nau GJ; Lancki DW; Kim DK; Fitch FW J Immunol; 1987 Aug; 139(3):657-64. PubMed ID: 2955046 [TBL] [Abstract][Full Text] [Related]
14. Graft-vs-host reaction limited to a class II MHC difference results in a selective deficiency in L3T4+ but not in Lyt-2+ T helper cell function. Moser M; Mizuochi T; Sharrow SO; Singer A; Shearer GM J Immunol; 1987 Mar; 138(5):1355-62. PubMed ID: 2949013 [TBL] [Abstract][Full Text] [Related]
15. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells. Thiele DL; Charley MR; Calomeni JA; Lipsky PE J Immunol; 1987 Jan; 138(1):51-7. PubMed ID: 2946780 [TBL] [Abstract][Full Text] [Related]
16. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones. Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760 [TBL] [Abstract][Full Text] [Related]
17. Analysis of lymphokine producing T helper cells at the clonal level. Wagner H; Krönke M; Pfizenmaier K; Röllinghoff M; Scheurich P; Hardt C Behring Inst Mitt; 1983 May; (72):73-7. PubMed ID: 6242343 [TBL] [Abstract][Full Text] [Related]
18. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens. Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262 [TBL] [Abstract][Full Text] [Related]
19. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells. Sato S; Azuma T; Shimizu J; Shima J; Kitagawa S; Hamaoka T; Fujiwara H J Immunol; 1988 Aug; 141(3):721-7. PubMed ID: 2456330 [TBL] [Abstract][Full Text] [Related]
20. Specificity, phenotype, and precursor frequency of primary cytolytic T lymphocytes specific for class II major histocompatibility antigens. Golding H; Singer A J Immunol; 1985 Sep; 135(3):1610-5. PubMed ID: 3874902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]